O2-5-4 Prevalence and prognostic impact of comorbidities in sarcomas: A population-based study of 3746 patients in Hong Kong.

MLA

Loong, Herbert Hf, et al. “O2-5-4 Prevalence and Prognostic Impact of Comorbidities in Sarcomas: A Population-Based Study of 3746 Patients in Hong Kong.” Annals of Oncology, vol. 30, Oct. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1093/annonc/mdz339.024.

APA

Loong, H. H., Wong, C. K., Ho, C.-W., Tse, T., Kwan, S.-C. S., Lau, Y.-M., & Leung, L. K. (2019). O2-5-4 Prevalence and prognostic impact of comorbidities in sarcomas: A population-based study of 3746 patients in Hong Kong. Annals of Oncology, 30, N.PAG. https://doi.org/10.1093/annonc/mdz339.024

Chicago

Loong, Herbert Hf, Carlos Kh Wong, Chu-Wa Ho, Teresa Tse, Sui-Chun Sampson Kwan, Yat-Ming Lau, and Linda Ks Leung. 2019. “O2-5-4 Prevalence and Prognostic Impact of Comorbidities in Sarcomas: A Population-Based Study of 3746 Patients in Hong Kong.” Annals of Oncology 30 (October): N.PAG. doi:10.1093/annonc/mdz339.024.